Epigenome-Wide Analysis of DNA Methylation in Parkinson’s Disease Cortex

Background: Epigenetic factors including DNA methylation contribute to specific patterns of gene expression. Gene–environment interactions can change the methylation status in the brain, and accumulation of these epigenetic changes over a lifespan may be co-responsible for a neurodegenerative diseas...

Full description

Bibliographic Details
Main Authors: Oliver Kaut, Ina Schmitt, Fabian Stahl, Holger Fröhlich, Per Hoffmann, Frank J. Gonzalez, Ullrich Wüllner
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/12/4/502
Description
Summary:Background: Epigenetic factors including DNA methylation contribute to specific patterns of gene expression. Gene–environment interactions can change the methylation status in the brain, and accumulation of these epigenetic changes over a lifespan may be co-responsible for a neurodegenerative disease like Parkinson’s disease, which that is characterised by a late onset in life. Aims: To determine epigenetic modifications in the brains of Parkinson’s disease patients. Patients and Methods: DNA methylation patterns were compared in the cortex tissue of 14 male PD patients and 10 male healthy individuals using the Illumina Methylation 450 K chip. Subsequently, DNA methylation of candidate genes was evaluated using bisulphite pyrosequencing, and DNA methylation of cytochrome P450 2E1 (<i>CYP2E1</i>) was characterized in DNA from blood mononuclear cells (259 PD patients and 182 healthy controls) and skin fibroblasts (10 PD patients and 5 healthy controls). Protein levels of <i>CYP2E1</i> were analysed using Western blot in human cortex and <i>knock-out</i> mice brain samples. Results: We found 35 hypomethylated and 22 hypermethylated genes with a methylation M-value difference >0.5. Decreased methylation of cytochrome P450 2E1 (<i>CYP2E1</i>) was associated with increased protein levels in PD brains, but in peripheral tissues, i.e., in blood cells and skin fibroblasts, DNA methylation of <i>CYP2E1</i> was unchanged. In <i>CYP2E1 knock-out</i> mice brain alpha-synuclein (<i>SNCA</i>) protein levels were down-regulated compared to wild-type mice, whereas treatment with trichloroethylene (TCE) up-regulated <i>CYP2E1</i> protein in a dose-dependent manner in cultured cells. We further identified an interconnected group of genes associated with oxidative stress, such as Methionine sulfoxide reductase A (<i>MSRA</i>) and tumour protein 73 (<i>TP73</i>) in the brain, which again were not paralleled in other tissues and appeared to indicate brain-specific changes. Conclusions: Our study revealed surprisingly few dysmethylated genes in a brain region less affected in PD. We confirmed hypomethylation of <i>CYP2E1</i>.
ISSN:2075-1729